The invention provides an application of a
donepezil or
gardenia jasminoides ellis-
phellodendron amurense component in preparation of a
cholinergic regulation-based immune
liver injury resisting
medicine, and belongs to the technical field of biological medicines. The pharmaceutical composition for resisting immunological
liver injury is a
donepezil component or a
gardenia jasminoides ellis-
phellodendron amurense component. The invention solves the problems of single action target and incomplete regulation and control mechanism of the existing immunological
liver injury treatment
medicine, provides a treatment scheme with anti-inflammatory, anti-oxidation, liver
cell apoptosis inhibition and
cholinergic system regulation and control functions, explores a brand new medical application of
donepezil, verifies the liver protection effect of donepezil in immunological liver injury, and provides a new application of donepezil in immunological liver injury. The application limitation is broken through; the
treatment effect of the Jashima component in an immune liver
injury model induced by
concanavalin A is defined, a dual regulation mechanism of inhibiting AChE expression and increasing alpha7 nAChR expression is disclosed, and the application scene is expanded; a multi-dimensional regulation and
control network of
cholinergic anti-inflammatory pathway-NF-kappa B inflammatory pathway-
hepatocyte apoptosis is constructed, and a more efficient and comprehensive
treatment strategy is provided for immunological liver injury.